Total Payments
$8,995
2024 Payments
$1,530
Companies
36
Transactions
585
Medicare Patients
6,406
Medicare Billing
$468,283
Payment Breakdown by Category
Food & Beverage$8,902 (99.0%)
Education$92.72 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,902 | 577 | 99.0% |
| Education | $92.72 | 8 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,136 | 166 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $786.67 | 42 | $0 (2024) |
| United Therapeutics Corporation | $770.88 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $770.62 | 57 | $0 (2024) |
| Genentech USA, Inc. | $754.64 | 56 | $0 (2024) |
| Insmed, Inc. | $403.66 | 21 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $388.83 | 25 | $0 (2024) |
| GENZYME CORPORATION | $373.35 | 19 | $0 (2024) |
| Mylan Specialty L.P. | $356.26 | 27 | $0 (2024) |
| Grifols USA, LLC | $356.20 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,530 | 87 | GlaxoSmithKline, LLC. ($365.10) |
| 2023 | $1,540 | 86 | GlaxoSmithKline, LLC. ($347.17) |
| 2022 | $1,152 | 79 | GlaxoSmithKline, LLC. ($297.37) |
| 2021 | $1,055 | 68 | GlaxoSmithKline, LLC. ($249.19) |
| 2020 | $849.35 | 62 | GlaxoSmithKline, LLC. ($262.22) |
| 2019 | $1,167 | 83 | Genentech USA, Inc. ($231.19) |
| 2018 | $1,022 | 76 | GlaxoSmithKline, LLC. ($281.73) |
| 2017 | $679.78 | 44 | United Therapeutics Corporation ($146.60) |
All Payment Transactions
585 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $31.38 | General |
| Category: Narcoplepsy | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/11/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/27/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Pulmonology | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/28/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,514 | 2,106 | $390,746 | $105,905 |
| 2022 | 20 | 1,479 | 2,001 | $388,619 | $93,080 |
| 2021 | 21 | 1,747 | 2,471 | $484,589 | $127,908 |
| 2020 | 26 | 1,666 | 3,726 | $495,053 | $141,390 |
Total Patients
6,406
Total Services
10,304
Medicare Billing
$468,283
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 329 | 555 | $72,150 | $32,228 | 44.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 72 | 140 | $29,400 | $12,428 | 42.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 41 | 41 | $13,325 | $11,565 | 86.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 165 | $25,080 | $9,405 | 37.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 342 | 517 | $95,645 | $9,001 | 9.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $18,816 | $6,347 | 33.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 55 | $15,125 | $5,070 | 33.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 135 | 149 | $40,975 | $3,421 | 8.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 29 | $6,525 | $2,598 | 39.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 35 | $3,500 | $2,507 | 71.6% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 38 | 42 | $31,500 | $2,252 | 7.1% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 26 | 26 | $6,500 | $2,161 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,300 | $1,321 | 40.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 42 | 42 | $2,100 | $1,194 | 56.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 18 | $3,600 | $1,067 | 29.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $1,850 | $1,052 | 56.9% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 51 | 53 | $11,925 | $921.04 | 7.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 29 | 29 | $5,800 | $744.38 | 12.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 17 | 20 | $980.00 | $182.00 | 18.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 20 | $200.00 | $168.00 | 84.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 18 | 21 | $750.00 | $141.54 | 18.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 16 | 17 | $1,700 | $132.43 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 332 | 507 | $65,910 | $29,522 | 44.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 62 | 153 | $32,130 | $11,511 | 35.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 341 | 499 | $92,315 | $8,795 | 9.5% |
About Dr. Garrettson Ellis, M.D
Dr. Garrettson Ellis, M.D is a Pulmonary Disease healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336145317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Garrettson Ellis, M.D has received a total of $8,995 in payments from pharmaceutical and medical device companies, with $1,530 received in 2024. These payments were reported across 585 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,902).
As a Medicare-enrolled provider, Ellis has provided services to 6,406 Medicare beneficiaries, totaling 10,304 services with total Medicare billing of $468,283. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Memphis, TN
- Active Since 06/23/2005
- Last Updated 06/21/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1336145317
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,060
- NUCALA (Biological) $801.69
- Xolair (Biological) $573.50
- ORENITRAM (Drug) $463.20
- DUPIXENT (Biological) $451.32
- OFEV (Drug) $426.66
- Arikayce (Drug) $350.61
- FASENRA (Biological) $308.98
- TYVASO (Drug) $307.68
- Prolastin-C Liquid (Biological) $299.42
- UPTRAVI (Drug) $218.87
- STIOLTO RESPIMAT (Drug) $197.52
- Yupelri (Drug) $195.76
- WAKIX (Drug) $191.50
- Esbriet (Biological) $167.48
- TEZSPIRE (Biological) $154.59
- ZERBAXA (Drug) $133.52
- YUPELRI (Drug) $123.76
- ANORO (Drug) $121.78
- SPIRIVA RESPIMAT (Drug) $109.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Memphis
Anthony Mattox, D.o, D.O
Pulmonary Disease — Payments: $21,781
Pulmonary Disease $21,781
Dr. Nathan Wilds, Md, MD
Pulmonary Disease — Payments: $20,941
Pulmonary Disease $20,941
Jeffrey Wright, M.d, M.D
Pulmonary Disease — Payments: $15,147
Pulmonary Disease $15,147
Robert Aguillard, Md, MD
Pulmonary Disease — Payments: $11,075
Pulmonary Disease $11,075
Roy Fox, Md, MD
Pulmonary Disease — Payments: $10,189
Pulmonary Disease $10,189
Dr. Kimberly Marsh, M.d, M.D
Pulmonary Disease — Payments: $9,654
Pulmonary Disease $9,654